BCAB vs KEYS · $5.9M cap vs P/E 57, rev $4.98B
Bioatla Inc (BCAB) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
BCAB currently screens at market cap $5.9M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the BCAB and KEYS stock pages for the full models.
Not investment advice.